Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system

Yiren Xu(Sutro Biopharma (United States)), John Lee(Sutro Biopharma (United States)), Cuong Tran(Sutro Biopharma (United States)), Tyler H. Heibeck(Sutro Biopharma (United States)), Willie D. Wang(Sutro Biopharma (United States)), Junhao Yang(Sutro Biopharma (United States)), Ryan Stafford(Sutro Biopharma (United States)), Alexander Steiner(Sutro Biopharma (United States)), Aaron K. Sato(Sutro Biopharma (United States)), Trevor J. Hallam(Sutro Biopharma (United States)), Gang Yin(Sutro Biopharma (United States))
mAbs
November 26, 2014
Cited by 96Open Access
Full Text

Abstract

Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement. Among extremely diverse architectures of bispecific antibodies, knobs-into-holes (KIHs) technology, which involves engineering CH3 domains to create either a "knob" or a "hole" in each heavy chain to promote heterodimerization, has been widely applied. Here, we describe the use of a cell-free expression system (Xpress CF) to produce KIH bispecific antibodies in multiple scaffolds, including 2-armed heterodimeric scFv-KIH and one-armed asymmetric BiTE-KIH with tandem scFv. Efficient KIH production can be achieved by manipulating the plasmid ratio between knob and hole, and further improved by addition of prefabricated knob or hole. These studies demonstrate the versatility of Xpress CF in KIH production and provide valuable insights into KIH construct design for better assembly and expression titer.


Related Papers

No related papers found

Powered by citation graph analysis